Request for Covid-19 Impact Assessment of this Report
Market Dynamics
The Artificial Organs & Bionic Implants market is growingdue to a number of factors such as huge demand for organ transplantation, lack of organ donors, technological advancements in the medical technologies,advancements made in theartificial organ and medical bionic implant procedures, increasing investments made for R&D activities by the government. Increasing aging population, rising road accidents with simultaneous increase in income level are further contributing to the market growth.
However, there are certain restraints to this market growth which includeexpensive devices, high costs of organ transplantation, fear of failure or malfunction and limited surgical experience.
Market Segmentation
The global artificial organs and bionic market is segmented based on type of products, technology used and type of fixation. Based on the product type, the market is segmented into Artificial organs (heart, liver, kidney, lungs and pancreas) and Bionics. The bionic market is further sub-segmented into vision bionics (bionic eye),orthopedic bionics (bionic finger, bionic limb, bionic leg and exoskeleton), ear bionics (Bone Anchored Hearing Aid),cardiac bionics (heart valves, pacemaker) and brain bionics (spinal cord stimulators, deep brain stimulators and vagus nerve stimulators). Based on technology, the market is segmented into mechanical and electronic bionics. Based on the type of fixation, the market is segmented into externally worn and implantable.
Geographic Analysis
North America holds the major market share in the global market, due to increased awareness and higher per capita income, followed by Asia-Pacific and Europe.Asia-Pacific is a potential market due to rising government initiatives and large consumer base. So, there is huge scope for new entrants in these emerging markets as penetration is low in these areas.
Key Companies
Some of the major players in the market are Berlin Heart GmbH, Edwards LifeSciences Corporation, Boston Scientific Corporation, Otto Bock Healthcare,Esko Bionics, Worldheart Corporation , F Hoffman-La Roche Ltd., Thoratec Corporation , Gambro AB, Jarvik Heart Inc., Lifenet Health.
The report contains comprehensive analysis on:
--> Artificial Organs & Bionic Implants Market Segments
--> Artificial Organs & Bionic Implants Market Drivers, Restraints and Opportunities
--> Artificial Organs & Bionic Implants Market Size & Forecast 2016 to 2022
--> Supply & Demand Value Chain
--> Artificial Organs & Bionic Implants Market Current Trends
--> Competition & Major Companies
--> Technology and R&D Status
--> Porters Five Force Analysis
--> Strategic and Critical Success Factor Analysis of Key Players
Regional analysis Artificial Organs & Bionic Implants Market includes
--> North America
>> US and Canada
--> Latin America
>> Mexico, Brazil, Argentina and Rest of Latin America
--> Western Europe
>> EU5 (Germany, France, Italy, Spain, U.K.)
>> Nordic Countries (Denmark, Finland, Norway, and Sweden)
>> Benelux (Belgium, The Netherlands, and Luxembourg)
>> Rest of Western Europe
--> Eastern Europe
>> Russia
>> Poland
>> Rest of Eastern Europe
--> Asia Pacific
>> China
>> India
>> Japan
>> Australia and New Zealand
>> Rest of Asia Pacific
--> Middle East and Africa
>> GCC countries (Saudi Arabia, Oman, Qatar, Bahrain, UAE and Kuwait)
>> South Africa
>> North Africa
>> Rest of Middle East and Africa
This report is an elaborate aggregation of primary inputs from industry experts and participants across the supply chain. It provides in-depth market segmentation that is derived from extensive product mapping exercises, macro-economic factors and other qualitative and quantitative insights. The impact of all such factors are delivered across multiple market segments and geographies.
Report Highlights::
--> Detailed Historical Overview (Market Origins, Product Launch Timeline, etc.)
--> Consumer and Pricing Analysis
--> Market dynamics of the industry
--> In-depth Market Segmentation
--> Historical and Projected Market Sizing in terms of volume and value
--> Recent market trends and Impact Factors
--> R&D Status and Technology Overview
--> Extensive Industry Structure Coverage
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...